Funder
National Institutes of Health
New York State Department of Health - Wadsworth Center
St. Jude Children's Research Hospital
American Lebanese Syrian Associated Charities
Subject
Infectious Diseases,Microbiology (medical),Immunology,Microbiology
Reference48 articles.
1. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms;Brown;Antimicrob Agents Chemother,1992
2. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid;Wallace;Antimicrob Agents Chemother,1991
3. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae;Swenson;Antimicrob Agents Chemother,1985
4. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary;Floto;Thorax,2016
5. Tigecycline is highly efficacious against Mycobacterium abscessus pulmonary disease;Ferro;Antimicrob Agents Chemother,2016
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献